常规结肠镜检查中不间断抗凝的安全性
单中心中断时间序列和比较队列分析均显示,术后出血和血栓栓塞事件在两种策略间无显著差异。作者认为在系统化抗凝管理方案下,不间断或中断抗凝似乎均可接受。
要点
- 在系统化抗凝管理方案下,不间断抗凝用于常规结肠镜未见术后出血或血栓栓塞风险显著增加。
- 不间断抗凝中心的术后出血均发生于术前停用抗凝药的患者。
- 圈套息肉切除与术后出血相关(OR 7.92),Elixhauser合并症指数≥6与血栓栓塞事件相关(OR 2.45)。
核心结论
- 在系统化抗凝管理方案下,连续或中断抗凝似乎均为常规结肠镜可接受的方法。
研究设计与样本
- 比较效果研究,纳入2016年1月1日至2022年12月31日在南加州13个消化科组组成的大型综合医疗系统接受门诊择期结肠镜的45至75岁服用华法林或直接口服抗凝药的患者。
- 一个高流量医学中心于2019年3月20日启动不间断抗凝方案,采用中断时间序列和比较队列分析比较30天术后出血和血栓栓塞风险。
- 共20284例符合条件,13011例纳入分析;平均年龄66.3至66.6岁,男性63%,白人56%。
主要发现
- 单中心中断时间序列中,方案实施前后术后出血粗率中断组2.52% vs 不间断组1.51%(P = .06),血栓栓塞事件.78% vs .91%(P = .72),均无差异。
- 比较队列分析中(不间断抗凝方案中心n = 1654;其他12个医疗服务区n = 10204),术后出血1.5% vs 1.1%(P = .25),血栓栓塞事件.8% vs .7%(P = .61),均无差异。
- 不间断抗凝方案中心所有术后出血均发生于结肠镜前停用抗凝药的患者。
- 多变量分析结果一致;圈套息肉切除与术后出血相关(OR 7.92;95% CI 4.84-12.97),黑人种族与术后出血相关(OR 1.77;95% CI 1.08-2.91),Elixhauser合并症指数评分≥6与血栓栓塞事件相关(OR 2.45;95% CI 1.09-5.51)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Data are lacking regarding the optimal periprocedural management of anticoagulation before an elective endoscopy. The aim of this study was to compare the safety of interrupted versus uninterrupted anticoagulation among patients undergoing routine colonoscopy. METHODS: A comparative effectiveness study was performed among patients aged 45 to 75 years. These patients were taking warfarin or a direct oral anticoagulant and underwent outpatient elective colonoscopy between January 1, 2016, and December 31, 2022, in a large integrated health care system comprising 13 gastroenterology groups in Southern California. One of the high-volume medical centers initiated an uninterrupted anticoagulation protocol on March 20, 2019. An interrupted time series and comparative cohort analysis was used to compare 30-day postprocedural bleeding and thromboembolic risk in patients managed with interrupted versus uninterrupted anticoagulation both within the high-volume medical center and across other medical centers. Multivariable logistic regression was performed with adjusted covariates, including patient age, sex, race/ethnicity, Elixhauser comorbidity index, CHA2DS2-VASc score, anticoagulation type, indication, and intervention (ie, biopsy, snare). RESULTS: A total of 20,284 patients met eligibility criteria, and 13,011 were included in analyses. The mean ages ranged from 66.3 to 66.6 years, and the majority of patients were male (63%) and white (56%). In the single-center interrupted time series, there was no difference in pre-implementation versus postimplementation of the uninterrupted anticoagulation protocol for either postprocedural bleeding (crude rate interrupted vs uninterrupted, 2.52% vs 1.51%; P = .06) or thromboembolic event (.78% vs .91%; P = .72). In the comparative cohort analysis (n = 1654 at the uninterrupted anticoagulation protocol center; n = 10,204 from the 12 other medical service areas), there was no difference in postprocedural bleeding (1.5% vs 1.1%; P = .25) or thromboembolic event (.8% vs .7%; P = .61). Of note, all postprocedural bleeds within the uninterrupted anticoagulation protocol center occurred in patients who had anticoagulant agents discontinued before colonoscopy. The findings were consistent in multivariable analysis. Snare polypectomy (odds ratio, 7.92; 95% CI, 4.84-12.97) and black race (odds ratio, 1.77; 95% CI, 1.08-2.91) were associated with postprocedural bleeding while an Elixhauser comorbidity index score ≥6 (odds ratio, 2.45; 95% CI, 1.09-5.51) was associated with a thromboembolic event. CONCLUSIONS: Continuous or interrupted anticoagulation both seem to be acceptable approaches for routine colonoscopy in the setting of a systematic protocol for anticoagulation management.
引用
- Giap AQ, Hang I, Chen Q, et al. Safety of uninterrupted anticoagulation in the setting of routine colonoscopy. Gastrointest Endosc. 2025. PMID: 40210014. doi:10.1016/j.gie.2025.04.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。